Holen Sie sich die Stockscreener-App
7.00
0.43%
0.03
Schlusskurs vom Vortag:
$6.97
Offen:
$7.03
24-Stunden-Volumen:
66,858
Relative Volume:
0.35
Marktkapitalisierung:
$22.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.80M
KGV:
-5.9829
EPS:
-1.17
Netto-Cashflow:
$-59.06M
1W Leistung:
-2.51%
1M Leistung:
+24.78%
6M Leistung:
+1,650%
1J Leistung:
+838.21%
1-Tages-Spanne:
$6.87
$7.235
1-Wochen-Bereich:
$6.83
$7.50
52-Wochen-Spanne:
$0.257
$7.75
Passage Bio Inc Stock (PASG) Company Profile
Firmenname
Passage Bio Inc
Sektor
Branche
Telefon
(267) 866-0312
Adresse
ONE COMMERCE SQUARE, PHILADELPHIA, PA
Vergleichen Sie PASG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
7.00 | 22.44M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-09-03 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-03-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-19 | Herabstufung | Goldman | Buy → Neutral |
| 2021-07-01 | Eingeleitet | Raymond James | Outperform |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-03-04 | Hochstufung | Goldman | Neutral → Buy |
| 2021-02-04 | Eingeleitet | Guggenheim | Buy |
| 2021-01-25 | Eingeleitet | Wedbush | Outperform |
| 2021-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-08-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-06-25 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-03-24 | Eingeleitet | Cowen | Outperform |
| 2020-03-24 | Eingeleitet | Goldman | Buy |
| 2020-03-24 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Passage Bio Inc Aktie (PASG) Neueste Nachrichten
Using AI based signals to follow Passage Bio Inc.July 2025 Decliners & Stepwise Swing Trade Plans - Newser
Using data models to predict Passage Bio Inc. stock movement2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
How to integrate Passage Bio Inc. into portfolio analysis toolsLong Setup & Low Risk High Win Rate Picks - Newser
Visual trend scoring systems applied to Passage Bio Inc.Short Setup & Low Drawdown Momentum Ideas - Newser
How moving averages guide Passage Bio Inc. trading2025 Market WrapUp & Safe Capital Growth Tips - Newser
Short interest data insights for Passage Bio Inc.Market Movers & Advanced Swing Trade Entry Plans - Newser
Will Passage Bio Inc. stock recover after recent drop2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Risk adjusted return profile for Passage Bio Inc. analyzed2025 Valuation Update & Real-Time Stock Movement Alerts - Newser
How high can Passage Bio Inc. stock go2025 Bull vs Bear & Weekly Breakout Watchlists - Newser
Long term hold vs stop loss in Passage Bio Inc.July 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Has Passage Bio Inc. found a price floor2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Using R and stats models for Passage Bio Inc. forecastingRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Advanced analytics toolkit walkthrough for Passage Bio Inc.July 2025 Movers & Precise Swing Trade Entry Alerts - Newser
Visual analytics tools that track Passage Bio Inc. performance2025 Market Trends & Expert Curated Trade Ideas - Newser
Passage Bio Inc. stock outlook for YEAR2025 Volatility Report & Weekly Consistent Profit Watchlists - Newser
Combining price and volume data for Passage Bio Inc.Weekly Market Outlook & Accurate Intraday Trade Tips - Newser
How hedge fund analytics apply to Passage Bio Inc. stock2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Will Passage Bio Inc. Benefit From Sector TailwindsJuly 2025 Gainers & Real-Time Stock Entry Alerts - beatles.ru
Can Passage Bio Inc. recover in the next quarterJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet - MSN
Analyzing Passage Bio Inc. with risk reward ratio chartsJuly 2025 Update & Breakout Confirmation Trade Signals - Newser
When is the best time to exit Passage Bio Inc.Portfolio Gains Summary & Daily Price Action Insights - Newser
Published on: 2025-09-08 21:23:23 - Newser
Backtesting results for Passage Bio Inc. trading strategiesWeekly Trend Recap & Daily Oversold Bounce Ideas - Newser
Chart based exit strategy for Passage Bio Inc.Treasury Yields & Real-Time Volume Triggers - Newser
Strategies to average down on Passage Bio Inc.2025 Earnings Impact & Reliable Breakout Stock Forecasts - Newser
Finanzdaten der Passage Bio Inc-Aktie (PASG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Passage Bio Inc-Aktie (PASG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):